By expenditures
| Name | Title | Type |
|---|---|---|
| Marilee Arsenault | Executive Director | Auditee |
| Ronald Carmark | Certified Public Accountant | Auditee |
| Michael Guyder | Managing Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 375748 | 2025 | 2025-12-18 | CBIZ CPAS PC | $5.18M |
| 327628 | 2024 | 2024-11-07 | Marcum LLP | $4.14M |
| 303175 | 2023 | 2024-04-10 | Marcum LLP | $2.96M |
| 49327 | 2022 | 2022-12-28 | Ronald Carmark CPA | $2.73M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 375748 | 2025 | 2025-12-18 | 1165261 | 2025-001 | Material Weakness | Yes | N |
| 375748 | 2025 | 2025-12-18 | 1165260 | 2025-001 | Material Weakness | Yes | N |
| 327628 | 2024 | 2024-11-07 | 1081320 | 2024-002 | Material Weakness | Yes | N |
| 327628 | 2024 | 2024-11-07 | 1081319 | 2024-002 | Material Weakness | Yes | N |
| 327628 | 2024 | 2024-11-07 | 1081318 | 2024-001 | Significant Deficiency | Yes | E |
| 327628 | 2024 | 2024-11-07 | 1081317 | 2024-001 | Significant Deficiency | Yes | E |
| 327628 | 2024 | 2024-11-07 | 504878 | 2024-002 | Material Weakness | Yes | N |
| 327628 | 2024 | 2024-11-07 | 504877 | 2024-002 | Material Weakness | Yes | N |
| 327628 | 2024 | 2024-11-07 | 504876 | 2024-001 | Significant Deficiency | Yes | E |
| 327628 | 2024 | 2024-11-07 | 504875 | 2024-001 | Significant Deficiency | Yes | E |
| 303175 | 2023 | 2024-04-10 | 969343 | 2023-002 | Material Weakness | - | N |
| 303175 | 2023 | 2024-04-10 | 969342 | 2023-002 | Material Weakness | - | N |
| 303175 | 2023 | 2024-04-10 | 969341 | 2023-001 | Significant Deficiency | - | E |
| 303175 | 2023 | 2024-04-10 | 969340 | 2023-001 | Significant Deficiency | - | E |
| 303175 | 2023 | 2024-04-10 | 392901 | 2023-002 | Material Weakness | - | N |
| 303175 | 2023 | 2024-04-10 | 392900 | 2023-002 | Material Weakness | - | N |
| 303175 | 2023 | 2024-04-10 | 392899 | 2023-001 | Significant Deficiency | - | E |
| 303175 | 2023 | 2024-04-10 | 392898 | 2023-001 | Significant Deficiency | - | E |